Paris-based drugmaker Sanofi is acquiring U,K,-based Vicebio to gain its molecular clamp vaccine technology, with the total ...

Zhong Lun is acting for LaNova. The Beijing-based law firm last year also advised LaNova on its $48 million series C1 ...